Explain this page
Arphra AIPlain-English read on HCA Healthcare, Inc.’s valuation06-08today
- Is HCA Undervalued? DCF Says Worth $7657d
- Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting9d
- Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting9d
- HCA Healthcare, Inc. to Present at May Conference47d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,778.83
+350.92% vs spot
Recommendation
Strong Buy
16 of 18 methods
Method spread
9bull7bear
±5% threshold
Analyst PT consensus: $527.45 (+33.71%)
Candlestick · 1Y
Open in chart workstation →HCA
389.97+4.70%H 556.52L 330.00MA50 436.17MA200 461.24Avg vol 1.3M
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.62% | +3.65% | -6.74% | -22.63% | -16.40% | -15.50% | +5.92% | +38.27% | +90.38% | +409.47% | +1171.71% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$24.83M
10 txns
Net flow
−$24.83M
Aftermarket
LiveLast trade
$394.48
444 sh
Bid
$394.37
1 sh
Ask
$394.70
10 sh
Spread
$0.330
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $19.11B | $1.62B | $7.15 |
| Q4 Dec 2025 | $19.51B | $1.88B | $8.14 |
| Q3 Sep 2025 | $19.16B | $1.64B | $6.96 |
| Q2 Jun 2025 | $18.61B | $1.65B | $6.83 |
| Q1 Mar 2025 | $18.32B | $1.61B | $6.45 |
| Q4 Dec 2024 | $18.29B | $1.44B | $5.63 |
Sector & industry today
LiveSectors
- Utilities+1.33%
- Basic Materials+0.95%
- Industrials+0.69%
- Consumer Cyclical+0.37%
- Technology+0.20%
- Financial Services+0.01%
- Healthcare-0.12%
- Energy-0.32%
- Real Estate-0.36%
- Consumer Defensive-0.48%
- Communication Services-0.73%
Top industries (issuer's industry highlighted)
- Medical - Care Facilities+0.41%
- Business Equipment & Supplies+3.25%
- Gold+2.89%
- Auto - Dealerships-2.67%
- Trucking-2.56%
- Silver+2.53%
- Broadcasting+2.38%
- Copper+2.09%
- Steel-2.03%
- Electrical Equipment & Parts+1.99%
- Auto - Recreational Vehicles+1.99%
- Oil & Gas Refining & Marketing-1.96%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$527.45
+33.71% upside
Low
$436.00
Median
$530.00
High
$635.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Is HCA Undervalued? DCF Says Worth $765gurufocus.com·Jun 10, 2026
- Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meetingbusinesswire.com·Jun 08, 2026
- Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meetingbusinesswire.com·Jun 08, 2026
- HCA Healthcare, Inc. to Present at May Conferencebusinesswire.com·Apr 30, 2026
Recent analyst activity
DB- Jun 04, 2026GradeMarket Perform → Market PerformHCA Healthcare Inc (HCA) PT Lowered to $413 at Bernstein SocGen Amid Policy RisksBernstein
- Jun 04, 2026PT$413.00HCA Healthcare Inc (HCA) PT Lowered to $413 at Bernstein SocGen Amid Policy RisksTruist Financial
- Jun 04, 2026PT$413.00HCA Healthcare price target lowered to $413 from $503 at BernsteinBernstein
Peers
Total assets
$60.72B
Total debt
$50.2B
Cash & equiv
$1.04B
Operating CF
$12.64B
Free cash flow
$7.69B
Buybacks
-$10.07B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
McAlevey Michael R officer: EVP & Chief Legal & Admin Off. | Sell | 1,694 | $903.54K | Feb 18, 2026 |
Wyatt Christopher F. officer: SVP & Controller | Sell | 4,000 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.02M | Feb 11, 2026 |
Berres Jennifer officer: SVP & Chief Human Res. Officer | Sell | 4,010 | $2.11M | Feb 11, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 5,162 | $2.57M | Feb 03, 2026 |
HAZEN SAMUEL N director, officer: CEO | Sell | 14,716 | $7.4M | Feb 03, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $75.6B | $11.97B | $6.78B | $28.38 | +8.97% |
| FY 2024 | $70.6B | $10.55B | $5.76B | $22.00 | +8.16% |
| FY 2023 | $64.97B | $9.63B | $5.24B | $18.96 | +8.07% |
| FY 2022 | $60.23B | $9.05B | $5.64B | $19.15 | +9.37% |
| FY 2021 | $58.75B | $9.68B | $6.96B | $21.16 | +11.84% |